Trial Profile
A dose finding study of oral LBH589 with radiation with or without chemotherapy for Stage III Non Small Cell Lung Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Jun 2016
Price :
$35
*
At a glance
- Drugs Panobinostat (Primary) ; Cisplatin; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 08 Jun 2016 Status changed from recruiting to completed.
- 25 Apr 2009 New trial record